This course has expired. View available courses.
Women's Health
Progesterone for luteal phase support in ART: a guide for fertility nurses
The use of progesterone for luteal phase support (LPS) in assisted reproductive technologies (ART) has become the standard of practice. RANZCOG recommends the use of LPS with progesterone inin-vitro fertilisation (IVF) as it is associated with improved live birth rates.
This course covers best-practice management of patients undergoing all forms of ART, and reviews the different vaginal progesterone treatment options currently available in Australia.
After completing this program, fertility nurses will be better able to understand the mechanism of action of progesterone and the essential role of LPS in optimising outcomes for patients undergoing ART.
This program is supported by an unrestricted educational grant provided from Besins.
DURATION
30 mins
PROFESSION
Nursing
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2022-12-31
The use of progesterone for luteal phase support (LPS) in assisted reproductive technologies (ART) has become the standard of practice. RANZCOG recommends the use of LPS with progesterone inin-vitro fertilisation (IVF) as it is associated with improved live birth rates.
This course covers best-practice management of patients undergoing all forms of ART, and reviews the different vaginal progesterone treatment options currently available in Australia.
After completing this program, fertility nurses will be better able to understand the mechanism of action of progesterone and the essential role of LPS in optimising outcomes for patients undergoing ART.
This program is supported by an unrestricted educational grant provided from Besins.
Faculty
Jan Mackenzie
Nurse Unit Manager & Committee Member of the Fertility Nurses of Australasia (FNA)
Learning objectives
Upon completing this continuing education program, participants will be better able to:
- Describe why luteal phase support (LPS) is essential in assisted reproductive technology (ART), including in-vitro fertilisation (IVF), intracytoplasmic sperm injection (ICSI) and intrauterine insemination (IUI)
- Review the role of progesterone as the gold standard treatment for optimising LPS
- Differentiate between the progesterone products available in Australia
- Implement a ‘best practice’ approach to the ongoing management of patients receiving LPS
#
of credits: 0
Duration: 30 mins
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
30 mins
Duration
Nursing
Profession
0
# of credits
Learning Objectives
Upon completing this continuing education program, participants will be better able to:
- Describe why luteal phase support (LPS) is essential in assisted reproductive technology (ART), including in-vitro fertilisation (IVF), intracytoplasmic sperm injection (ICSI) and intrauterine insemination (IUI)
- Review the role of progesterone as the gold standard treatment for optimising LPS
- Differentiate between the progesterone products available in Australia
- Implement a ‘best practice’ approach to the ongoing management of patients receiving LPS
Unaccredited
ACCREDITATION
Women's Health
Learning Category
Pregnancy, Testosterone Deficiency
Topic
0
Price
2022-12-31
Expiry Date
AUS
Region/Language
Course Description
The use of progesterone for luteal phase support (LPS) in assisted reproductive technologies (ART) has become the standard of practice. RANZCOG recommends the use of LPS with progesterone inin-vitro fertilisation (IVF) as it is associated with improved live birth rates.
This course covers best-practice management of patients undergoing all forms of ART, and reviews the different vaginal progesterone treatment options currently available in Australia.
After completing this program, fertility nurses will be better able to understand the mechanism of action of progesterone and the essential role of LPS in optimising outcomes for patients undergoing ART.
This program is supported by an unrestricted educational grant provided from Besins.
Faculty
Jan Mackenzie
Nurse Unit Manager & Committee Member of the Fertility Nurses of Australasia (FNA)
Accreditation
30 mins
Duration
0
Price
0
# of credits
